Friday, July 10, 2026

Drug profile · INN

sitagliptin fumarate

sitagliptin fumarate (SITAGLIPTIN SUN) is a dipeptidyl peptidase iv inhibitor.

EMA: approved Alimentary tract and metabolism (A10) A10BH01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sitagliptin fumarate
Class
Alimentary tract and metabolism (A10)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

sitagliptin fumarate (SITAGLIPTIN SUN) is a dipeptidyl peptidase iv inhibitor.

Key facts

INN sitagliptin fumarate
Brand SITAGLIPTIN SUN
Mechanism Dipeptidyl peptidase IV inhibitor
Target Dipeptidyl peptidase 4
Therapeutic class Alimentary tract and metabolism (A10)
ATC code A10BH01

Mechanism of action

Dipeptidyl peptidase IV inhibitor

Primary target: Dipeptidyl peptidase 4

Approval history

Authority Status Date
EMA approved

Related & competitor drugs

  1. agalsidase alfa Alimentary tract and metabolism (A16)
  2. alogliptin Alimentary tract and metabolism (A10)
  3. alogliptin benzoate Alimentary tract and metabolism (A10)
  4. aprepitant Alimentary tract and metabolism (A04)
  5. budesonide Alimentary tract and metabolism (A07)
  6. canagliflozin Alimentary tract and metabolism (A10)

Frequently asked questions

What is sitagliptin fumarate?

sitagliptin fumarate (SITAGLIPTIN SUN) is a dipeptidyl peptidase iv inhibitor.

What is the brand name for sitagliptin fumarate?

SITAGLIPTIN SUN is a marketed brand name for sitagliptin fumarate. Check FDA Drugs@FDA for the current US label holder and prescribing information.